Cargando…

Evaluation of HIV-specific T-cell responses in HIV-infected older patients with controlled viremia on long-term antiretroviral therapy

HIV-infected older individuals may have a diminished immune response because of exhaustion/immune aging of T-cells. Therefore, we have investigated HIV-specific CD4 and CD8 T-cell responses in 100 HIV-infected patients (HIV(+)) who have aged on long-term antiretroviral therapy (ART) and achieved con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behrens, Nicole E., Wertheimer, Anne, Love, Maria B., Klotz, Stephen A., Ahmad, Nafees
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498024/ https://www.ncbi.nlm.nih.gov/pubmed/32941433 http://dx.doi.org/10.1371/journal.pone.0236320

Ejemplares similares

Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy
por: Behrens, Nicole E., et al.
Publicado: (2018)

HIV Infection-Associated Frailty: The Solution for Now Is Antiretroviral Drugs: A Perspective
por: Klotz, Stephen A., et al.
Publicado: (2019)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy
por: Jacobs, Jana L., et al.
Publicado: (2020)

Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia
por: Gandhi, Monica, et al.
Publicado: (2023)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013)

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
por: Christopoulos, Katerina A, et al.
Publicado: (2022)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy
por: Younas, Mehwish, et al.
Publicado: (2021)

Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy
por: Cillo, Anthony R., et al.
Publicado: (2014)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
por: Gaifer, Zied, et al.
Publicado: (2020)

Phenotypic frailty in people living with HIV is not correlated with age or immunosenescence
por: Klotz, Stephen A., et al.
Publicado: (2022)

HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
por: Mavigner, Maud, et al.
Publicado: (2009)

Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya
por: Aoko, Appolonia, et al.
Publicado: (2023)

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
por: Tosiano, Melissa A., et al.
Publicado: (2022)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020)

Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging
por: Shete, Ashwini, et al.
Publicado: (2023)

HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses
por: Prazuck, Thierry, et al.
Publicado: (2013)

Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome
por: Pasternak, Alexander O., et al.
Publicado: (2009)

Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors
por: Prabhu, Varsha M., et al.
Publicado: (2019)

Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016)

Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8(+) T cells
por: Takata, Hiroshi, et al.
Publicado: (2022)

Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
por: Lv, Shiyun, et al.
Publicado: (2023)

424. Southern Arizona Town: Homes Colonized by Kissing Bugs. Is Chagas Disease Being Transmitted?
por: Beatty, Norman, et al.
Publicado: (2018)

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
por: Widera, Marek, et al.
Publicado: (2017)

More than ten years without any detectable HIV viremia: exceptionally long-term non-progressive HIV infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients
por: Delaugerre, Constance, et al.
Publicado: (2012)

Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa
por: Fielding, Katherine, et al.
Publicado: (2011)

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations
por: Winckelmann, Anni, et al.
Publicado: (2017)

Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors
por: Cellerai, Cristina, et al.
Publicado: (2011)

Nonsuppressible viremia during HIV-1 therapy meets molecular virology
por: Emery, Ann, et al.
Publicado: (2023)

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
por: Elvstam, Olof, et al.
Publicado: (2017)

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2011)

Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation
por: Bull, Marta E., et al.
Publicado: (2018)

Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy
por: Erdmann, Nathaniel B., et al.
Publicado: (2018)

Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross‐sectional population‐based study
por: Kennedy, Caitlin E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rrusudo92dr7qbn0ikqboea1kf